Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy vs Radiotherapy for Ulcerated Cutaneous Metastases
NCT00918593Phase 2Withdrawn
- Sponsor
- Rigshospitalet
- Start
- Dec 2009
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bleomycin in cutaneous metastasis (CM), sponsored by Rigshospitalet. Planned start Dec 2009; status: withdrawn.
02
Drugs
bleomycin
03
Conditions
cutaneous metastasis (CM)
Beyond the preview
Go deeper on NCT00918593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918593.